HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2003
4801	4801 Pavletic SZ, Bociek RG, Foran JM, Rubocki RJ, Kuszynski CA, et al. Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation TRANSPLANTATION. 2003 SEP 15; 76 (5): 877-881	3	9	3	10
4802	4802 Belizaire AK, Tchistiakova L, St-Pierre Y, Alakhov V Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2003 SEP 26; 309 (3): 625-630	0	8	0	49
4803	4803 Foster RD, Pham S, Li S, Aitouche A Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade TRANSPLANTATION. 2003 SEP 27; 76 (6): 988-994	18	28	12	21
4804	4804 Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, et al. Living donor liver transplantation and tolerance: A potential strategy in cholangiocarcinoma TRANSPLANTATION. 2003 SEP 27; 76 (6): 1003-1006	9	29	8	20
4805	4805 Pavlova A, Bjork I Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases BIOCHEMISTRY. 2003 SEP 30; 42 (38): 11326-11333	0	10	0	42
4806	4806 Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, et al. The origin and liver repopulating capacity of murine oval cells PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 SEP 30; 100: 11881-11888	2	202	5	56
4807	4807 Kolb HJ, Schmid C, Chen XA, Woiciechowski A, Roskrow M, et al. Adoptive immunotherapy in chimeras with donor lymphocytes ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 110-120	4	14	28	88
4808	4808 Kramm CM Alternative concepts of suicide gene therapy for graft-versus-host disease after adoptive immunotherapy ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 132-138	0	2	6	36
4809	4809 Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, et al. Infliximab for steroid-refractory acute GVHD: A case series AMERICAN JOURNAL OF HEMATOLOGY. 2003 OCT; 74 (2): 119-124	7	50	3	24
4810	4810 Nachbaur D, Larcher C, Kircher B, Eibl G, Nussbaumer W, et al. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation ANNALS OF HEMATOLOGY. 2003 OCT; 82 (10): 621-627	0	15	10	27
#	Date / Author / Journal	LCS	GCS	LCR	CR
4811	4811 Shapiro R, Jordan ML, Basu A, Scantlebury V, Potdar S, et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning ANNALS OF SURGERY. 2003 OCT; 238 (4): 520-525	13	68	5	16
4812	4812 Tewsa B, Wilhelm J, Summerer D, Strerath M, Marx A, et al. Application of the C4 '-alkylated deoxyribose primer system (CAPS) in allele-specific real-time PCR for increased selectivity in discrimination of single nucleotide sequence variants BIOLOGICAL CHEMISTRY. 2003 OCT-NOV; 384 (10-11): 1533-1541	0	10	11	26
4813	4813 Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, et al. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 OCT; 9 (10): 616-632	5	18	3	49
4814	4814 Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, et al. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 OCT; 9 (10): 649-656	3	16	10	20
4815	4815 Takeuchi Y, Yoshizaki G, Takeuchi T Generation of live fry from intraperitoneally transplanted primordial germ cells in rainbow trout BIOLOGY OF REPRODUCTION. 2003 OCT; 69 (4): 1142-1149	11	43	2	24
4816	4816 Chou PM, Olszewski M, Huang W, Silva M, Kletzel M Platelet chimerism by polymerase chain reaction (PCR) utilizing variable number of tandem repeats (VNTR) in allogeneic stem cell transplant in children: a new novel approach to full chimerism analysis BONE MARROW TRANSPLANTATION. 2003 OCT; 32 (8): 825-828	0	1	13	20
4817	4817 Baron F, Baudoux E, Frere P, Tourqui S, Schaaf-Lafontaine N, et al. Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC BONE MARROW TRANSPLANTATION. 2003 OCT; 32 (8): 829-834	1	2	22	30
4818	4818 Nachbaur D, Kircher B, Eisendle K, Latzer K, Haun M, et al. Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation BRITISH JOURNAL OF HAEMATOLOGY. 2003 OCT; 123 (1): 119-126	3	10	22	34
4819	4819 D'Sa S, Peggs K, Pizzey A, Verfuerth S, Thuraisundaram D, et al. T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions BRITISH JOURNAL OF HAEMATOLOGY. 2003 OCT; 123 (2): 309-322	0	35	12	39
4820	4820 Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, et al. A novel monoclonal antibody design for radioimmunotherapy CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2003 OCT; 18 (5): 751-759	1	18	1	45
#	Date / Author / Journal	LCS	GCS	LCR	CR
4821	4821 Reams D, McAdams HP, Howell DN, Steele MP, Davis RD, et al. Posttransplant lymphoproliferative disorder - Incidence, presentation, and response to treatment in lung transplant recipients CHEST. 2003 OCT; 124 (4): 1242-1249	0	0	2	22
4822	4822 Petruzzo P, Revillard JP, Kanitakis J, Lanzetta M, Hakim NS, et al. First human double hand transplantation: efficacy of a conventional immunosuppressive protocol CLINICAL TRANSPLANTATION. 2003 OCT; 17 (5): 455-460	3	23	3	27
4823	4823 Ruhin B, Creuzet S, Vincent C, Benouaiche L, Le Douarin NM, et al. Patterning of the hyoid cartilage depends upon signals arising from the ventral foregut endoderm DEVELOPMENTAL DYNAMICS. 2003 OCT; 228 (2): 239-246	2	50	4	20
4824	4824 Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells DIABETOLOGIA. 2003 OCT; 46 (10): 1366-1374	9	115	7	42
4825	4825 Xanthou G, Williams TJ, Pease JE Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation EUROPEAN JOURNAL OF IMMUNOLOGY. 2003 OCT; 33 (10): 2927-2936	0	46	0	32
4826	4826 Turgeon NA, Banuelos SJ, Shultz LD, Lyons BL, Iwakoshi N, et al. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta(2)-microglobulin-null mice EXPERIMENTAL BIOLOGY AND MEDICINE. 2003 OCT; 228 (9): 1096-1104	1	6	7	38
4827	4827 Barge RMY, Osanto S, Marijt WAFE, Starrenburg CWJI, Fibbe WE, et al. Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 865-872	4	24	21	32
4828	4828 Faucher C, Mohty M, Vey N, Gaugler B, Bilger K, et al. Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 873-880	2	14	16	36
4829	4829 Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, et al. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507 EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 911-923	7	21	11	57
4830	4830 Wu CJ, Hochberg EP, Rogers SA, Kutok JL, Biernacki M, et al. Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 924-933	9	12	25	32
#	Date / Author / Journal	LCS	GCS	LCR	CR
4831	4831 Fernandez-Aviles F, Urbano-Ispizua A, Aymerich M, Rovira M, Martinez C, et al. Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 934-940	0	4	18	31
4832	4832 Yamaha E, Murakami M, Hada K, Otani S, Fujimoto T, et al. Recovery of fertility in male hybrids of a cross between goldfish and common carp by transplantation of PGC (primordial germ cell)-containing graft GENETICA. 2003 OCT; 119 (2): 121-131	7	39	5	34
4833	4833 Clouston A, Vanags DM, Gu WY, Powell EE, Jonsson JR Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism. HEPATOLOGY. 2003 OCT; 38 (4): 371A-371A	0	0	0	0
4834	4834 Ng IOL, Chan KL, Shek WH, Lee JMF, Fong DYT, et al. High frequency of chimerism in transplanted livers HEPATOLOGY. 2003 OCT; 38 (4): 989-998	21	50	15	36
4835	4835 Ansari MJI, Abdi R Emerging immunomodulatory therapies targeting the co-stimulatory pathways for the prevention of transplant rejection IDRUGS. 2003 OCT; 6 (10): 964-969	0	6	8	84
4836	4836 Jin YZ, Zhang QY, Hao B, Gao X, Guo YL, et al. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA41g gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats IMMUNOLOGY. 2003 OCT; 110 (2): 275-286	7	13	24	52
4837	4837 Slavin S Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation INTERNATIONAL JOURNAL OF HEMATOLOGY. 2003 OCT; 78 (3): 195-207	0	6	31	93
4838	4838 Gordon N, Mullen CA, Tran H, Worth L, Almaguer DG, et al. Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 OCT; 25 (10): 824-826	0	6	6	23
4839	4839 Matthes-Martin S, Lion T, Haas OA, Frommlet F, Daxberger H, et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection LEUKEMIA. 2003 OCT; 17 (10): 1934-1942	0	30	54	70
4840	4840 Tamaki H, Ikegame K, Kawakami M, Fujioka T, Tsuboi A, et al. Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin LEUKEMIA. 2003 OCT; 17 (10): 2052-2054	7	14	6	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
4841	4841 Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST Facilitating cells as a venue to establish mixed chimerism and tolerance PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 348-357	8	16	34	65
4842	4842 Venzke A, Ganschow R, Grabhorn E, Rogiers X, Burdelski M Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 404-407	1	3	2	18
4843	4843 Maksimenko A, Malvy C, Lambert G, Bertrand JR, Fattal E, et al. Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies PHARMACEUTICAL RESEARCH. 2003 OCT; 20 (10): 1565-1567	0	19	0	5
4844	4844 Brocca S, Secundo F, Ossola M, Alberghina L, Carrea G, et al. Sequence of the lid affects activity and specificity of Candida rugosa lipase isoenzymes PROTEIN SCIENCE. 2003 OCT; 12 (10): 2312-2319	0	32	0	36
4845	4845 Pruss A, Heymann GA, Hell A, Kalus UJ, Krausch D, et al. Acute intravascular hemolysis after transfusion of a chimeric RBC unit TRANSFUSION. 2003 OCT; 43 (10): 1449-1451	3	14	2	15
4846	4846 Zhou W, Ohdan H, Tanaka Y, Hara H, Tokita D, et al. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant TRANSPLANT IMMUNOLOGY. 2003 OCT-NOV; 12 (1): 9-18	0	8	2	38
4847	4847 Bittmann I, Bottino A, Baretton GB, Gerbes AL, Zachoval R, et al. The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation-a clinico-pathological study VIRCHOWS ARCHIV. 2003 OCT; 443 (4): 541-548	1	3	7	24
4848	4848 van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MCH, de Weger RA, et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2(-/-) gamma c(-/-) double-mutant mice BLOOD. 2003 OCT 1; 102 (7): 2522-2531	0	60	10	39
4849	4849 Horwitz ME, Uzel G, Linton GF, Miller JA, Brown MR, et al. Persistent Mycobactetium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency BLOOD. 2003 OCT 1; 102 (7): 2692-2694	0	14	2	9
4850	4850 Creevy KE, Bauer TR, Tuschong LM, Embree LJ, Silverstone AM, et al. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 2003 OCT 15; 95 (3-4): 113-121	6	15	3	20
#	Date / Author / Journal	LCS	GCS	LCR	CR
4851	4851 Xu QB, Zhang ZY, Davison F, Hu YH Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice CIRCULATION RESEARCH. 2003 OCT 17; 93 (8): E76-E86	2	98	3	55
4852	4852 Avivi I, Robinson S, Goldstone A Clinical use of rituximab in haematological malignancies BRITISH JOURNAL OF CANCER. 2003 OCT 20; 89 (8): 1389-1394	0	30	0	43
4853	4853 Schott E, Bonasio R, Ploegh HL Elimination in vivo of developing T cells by natural killer cells JOURNAL OF EXPERIMENTAL MEDICINE. 2003 OCT 20; 198 (8): 1213-1224	0	16	1	59
4854	4854 Takatu A, Nash RA, Zaucha YM, Little MT, Georges GE, et al. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 NOV; 9 (11): 674-682	3	6	15	35
4855	4855 Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 NOV; 9 (11): 689-697	2	19	10	29
4856	4856 Lee JJ, Nam CE, Kook H, Maciejewski JP, Kim YK, et al. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation BONE MARROW TRANSPLANTATION. 2003 NOV; 32 (9): 947-952	2	8	2	34
4857	4857 van Royen-Kerkhof A, Wulffraat NM, Kamphuis SSM, Brooimans RA, de Weger RA, et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodefficient patient BONE MARROW TRANSPLANTATION. 2003 NOV; 32 (10): 1027-1030	0	2	0	9
4858	4858 Luft T, Moos M, Goldschmidt H, Ho AD, Gorner M Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma BRITISH JOURNAL OF HAEMATOLOGY. 2003 NOV; 123 (4): 646-653	4	13	15	33
4859	4859 Leckel K, Beecken WD, Jonas D, Oppermann E, Coman MC, et al. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003 NOV; 134 (2): 238-245	0	13	0	27
4860	4860 Santmyire-Rosenberger B, Dugan EM Skin involvement in dermatomyositis CURRENT OPINION IN RHEUMATOLOGY. 2003 NOV; 15 (6): 714-722	0	22	1	92
#	Date / Author / Journal	LCS	GCS	LCR	CR
4861	4861 Alexandre P, Wassef M The isthmic organizer links anteroposterior and dorsoventral patterning in the mid/hindbrain by generating roof plate structures DEVELOPMENT. 2003 NOV; 130 (22): 5331-5338	0	21	9	41
4862	4862 Chen HR, Ji SQ, Wang HX, Yan HM, Zhu L, et al. Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion EXPERIMENTAL HEMATOLOGY. 2003 NOV; 31 (11): 1019-1025	4	19	7	36
4863	4863 Barker JE, Schuldt AJT, Lessard ML, Jude CD, Vogler CA, et al. Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII EXPERIMENTAL HEMATOLOGY. 2003 NOV; 31 (11): 1112-1118	0	1	12	28
4864	4864 Faden RR, Dawson L, Bateman-House AS, Agnew DM, Bok H, et al. Public stem cell banks: Considerations of justice in stem cell research and therapy HASTINGS CENTER REPORT. 2003 NOV-DEC; 33 (6): 13-27	0	35	4	35
4865	4865 Sato Y, Ichida T, Watanabe H, Yamamoto S, Abo T, et al. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation HEPATO-GASTROENTEROLOGY. 2003 NOV-DEC; 50 (54): 2161-2165	0	10	4	33
4866	4866 Margalit A, Fishman S, Berko D, Engberg J, Gross G Chimeric beta 2 microglobulin/CD3 zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells INTERNATIONAL IMMUNOLOGY. 2003 NOV; 15 (11): 1379-1387	0	8	0	42
4867	4867 Neff T, Horn PA, Peterson LJ, Thomasson BM, Thompson J, et al. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model JOURNAL OF CLINICAL INVESTIGATION. 2003 NOV; 112 (10): 1581-1588	8	70	2	37
4868	4868 Muramatsu K, Valenzuela RG, Bishop AT Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer JOURNAL OF ORTHOPAEDIC RESEARCH. 2003 NOV; 21 (6): 1056-1062	10	21	15	31
4869	4869 Muramatsu K, Kurokawa Y, Ihara K, Sakamoto S, Song YX, et al. Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation JOURNAL OF SURGICAL RESEARCH. 2003 NOV; 115 (1): 106-112	5	8	8	27
4870	4870 van Poelgeest EP, Baelde HJ, Lagaaij EL, Sijpkens YWJ, de Heer E, et al. Endothelial cell chimerism after kidney transplantation occurs preferentially in women. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003 NOV; 14: 416A-416A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4871	4871 Hagemeister FB Mantle cell lymphoma: Non-myeloablative versus dose-intensive therapy LEUKEMIA & LYMPHOMA. 2003 NOV; 44: S69-S75	0	3	1	29
4872	4872 Turkiewicz D, Gorczynska E, Toporski J, Kalwak K, Rybka B, et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes LEUKEMIA RESEARCH. 2003 NOV; 27 (11): 993-998	6	6	12	18
4873	4873 Olszewski WL, Interewicz B, Maksymowicz M, Durlik M Biological aspects of limb transplantation: I. Migration of transplanted bone marrow cells into recipient PLASTIC AND RECONSTRUCTIVE SURGERY. 2003 NOV; 112 (6): 1628-1635	1	1	5	17
4874	4874 Ebrahimi-Rad M, Nikbin B, Mehrsai A, Pourmand G Outcome of 18 cases of simultaneous kidney and donor-specific bone marrow transplantation TRANSPLANTATION PROCEEDINGS. 2003 NOV; 35 (7): 2761-2762	0	1	6	8
4875	4875 van Tellingen O, Buckle T, Jonker JW, van der Valk MA, Beijnen JH P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo BRITISH JOURNAL OF CANCER. 2003 NOV 3; 89 (9): 1776-1782	0	19	0	27
4876	4876 Strutz-Seebohm N, Werner M, Madsen DM, Seebohm G, Zheng Y, et al. Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 7; 278 (45): 44691-44701	0	8	4	46
4877	4877 Heemskerk MHM, Hoogeboom M, de Paus RA, Kester MGD, van der Hoorn MAWG, et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region BLOOD. 2003 NOV 15; 102 (10): 3530-3540	3	87	3	42
4878	4878 Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors BLOOD. 2003 NOV 15; 102 (10): 3829-3836	41	102	31	72
4879	4879 Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, et al. Male DNA in female donor apheresis and CD34-enriched products BLOOD. 2003 NOV 15; 102 (10): 3845-3847	20	39	5	14
4880	4880 Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block LANCET. 2003 NOV 15; 362 (9396): 1617-1623	15	60	9	42
#	Date / Author / Journal	LCS	GCS	LCR	CR
4881	4881 Sun WJ, Wang QX, Zhang LH, Liu YS, Zhang M, et al. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin TRANSPLANTATION. 2003 NOV 15; 76 (9): 1351-1359	0	19	7	30
4882	4882 Juliusson G, Malm C, Karlsson K, Backstrom G Donor-derived epithelial cells in buccal mucosa smears following allogeneic hematopoietic stem cell transplantation in 54 patients: Usually mixed chimerism, but level not related to procedure, time after transplantation, or graft-versus-host disease. BLOOD. 2003 NOV 16; 102 (11): 155B-155B	0	0	0	0
4883	4883 Panse JP, Heimfeld S, Guthrie KA, Maris M, Maloney DG, et al. Allogeneic peripheral blood graft composition affects early T-cell chimerism and later clinical outcomes after nonmyeloablative conditioning. BLOOD. 2003 NOV 16; 102 (11): 240A-240A	0	0	0	0
4884	4884 Abdulmalik O, Hayashi S, Merchant A, Chen QK, Yang JS, et al. Complete correction of sickle cell disease pathophysiology in high-level allogeneic chimeras created by a strategy of in utero hematopoietic cell transplantation with postnatal enhancement of chimerism. BLOOD. 2003 NOV 16; 102 (11): 263A-263A	0	0	0	0
4885	4885 Berger MG, Gallot D, Tchirkov A, Berger J, Pigeon P, et al. Mesenchymal cells improved human/rat microchimerism in Wistar rat after in utero transplantation (IUT). BLOOD. 2003 NOV 16; 102 (11): 394B-394B	0	0	0	0
4886	4886 Saito A, Chiba S, Ogawa S, Kanda Y, Hirai H Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia. BLOOD. 2003 NOV 16; 102 (11): 394B-394B	0	0	0	0
4887	4887 Lee MJ, Seo JJ, Choi ES, Ghim TT Is there a prognostic significance of mixed chimerism in children with acute leukemia after allogeneic bone marrow transplantation? BLOOD. 2003 NOV 16; 102 (11): 398B-399B	0	0	0	0
4888	4888 Moustafa ME, Srivastava AS, Nedelcu E, Shenouda SS, Minev B, et al. Chimerism and tolerance after in utero transplantation of ES cells. BLOOD. 2003 NOV 16; 102 (11): 399B-399B	0	0	0	0
4889	4889 Lucesole M, Poloni A, Capelli D, Montanari M, Cecchi S, et al. Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine. BLOOD. 2003 NOV 16; 102 (11): 400B-400B	0	0	0	0
4890	4890 Milani R, Longoni P, Rizzo E, Carrabba M, Dodero A, et al. Low-dose alemtuzumab in nonmyeloablative conditioning for allogeneic transplantation: Influence on recovery and chimerism of dendritic cells. BLOOD. 2003 NOV 16; 102 (11): 401B-401B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4891	4891 Hirano T, Miyajima H, Tateno M, Okumura K, Oshimi K Chimerism and graft-versus-tumor effect (GVT) on murine mini-transplantation model. BLOOD. 2003 NOV 16; 102 (11): 403B-403B	0	0	0	0
4892	4892 Naparstek E, Vainas O, Eshel R Real-time PCR SNP assay for monitoring chimerism after allogeneic stem cell transplantation. BLOOD. 2003 NOV 16; 102 (11): 433B-433B	0	0	0	0
4893	4893 Matthes-Martin S, Lion T, Haas OA, Frommlet F, Peters C, et al. Lineage-specific chimerism after stem cell transplantation in children following reduced intensity conditioning: Potential predictive value of NK cell chimerism for late graft rejection. BLOOD. 2003 NOV 16; 102 (11): 454A-455A	0	0	0	0
4894	4894 Bauer TR, Creevy KE, Gu YC, Tuschong LM, Embree LJ, et al. Stable mixed chimerism following a non-myeloabative transplant regimen corrects the disease phenotype in dogs with the primary immunodeficiency disease canine leukocyte adhesion deficiency. BLOOD. 2003 NOV 16; 102 (11): 456A-456A	1	1	0	0
4895	4895 Shields LE, Gaur LK, Andrews RG Chimerism after in utero hematopoietic stem cell transplantation in non-human primates is unchanged by fetal immune suppression or postnatal donor stem cell infusion. BLOOD. 2003 NOV 16; 102 (11): 456A-456A	0	0	0	0
4896	4896 Fukuda T, Storb R, Gooley T, Santos EB, Sandmaier BM DLA-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning: Achievement of full donor chimerism by donor lymphocyte infusion. BLOOD. 2003 NOV 16; 102 (11): 458A-458A	0	1	0	0
4897	4897 De Angelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, et al. Extended follow-up of patients treated with imatinib mesylate (Gleevec (R)) for CML relapse following allogeneic transplantation: Durable cytogenetic remission and conversion to complete donor chimerism without GVHD. BLOOD. 2003 NOV 16; 102 (11): 462B-462B	0	1	0	0
4898	4898 Huff CA, Jones RJ, Flinn I, Vogelsang GB, Luznik L, et al. Full donor chimerism is required for stable engraftment and durable disease control after nonmyeloablative (NM) allogeneic blood or marrow transplants (BMT). BLOOD. 2003 NOV 16; 102 (11): 467A-467A	0	0	0	0
4899	4899 Burt RK, Oyama Y, Traynor A, Verda L, Barr W Complete remission of rheumatoid arthritis following allogeneic hematopoietic stem cell transplantation induced mixed chimerism. BLOOD. 2003 NOV 16; 102 (11): 468B-468B	0	0	0	0
4900	4900 Michallet ASAS, Nicolini FF, Tremisi JPJP, Dubois VV, Hayette SS, et al. Analyzis of the toxicity and efficacy of donor lymphocyte infusions (DLI) after reduced intensity conditioning regimen allogeneic transplantations (RICT), given for either mixed chimerism and/or persistent disease. BLOOD. 2003 NOV 16; 102 (11): 470B-470B	0	0	0	0

Date / Author / Journal

LCS

GCS

LCR

2003

4801

4801 Pavletic SZ, Bociek RG, Foran JM, Rubocki RJ, Kuszynski CA, et al.

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation

TRANSPLANTATION. 2003 SEP 15; 76 (5): 877-881

4802

4802 Belizaire AK, Tchistiakova L, St-Pierre Y, Alakhov V

Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2003 SEP 26; 309 (3): 625-630

4803

4803 Foster RD, Pham S, Li S, Aitouche A

Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade

TRANSPLANTATION. 2003 SEP 27; 76 (6): 988-994

4804

4804 Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, et al.

Living donor liver transplantation and tolerance: A potential strategy in cholangiocarcinoma

TRANSPLANTATION. 2003 SEP 27; 76 (6): 1003-1006

4805

4805 Pavlova A, Bjork I

Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases

BIOCHEMISTRY. 2003 SEP 30; 42 (38): 11326-11333

4806

4806 Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, et al.

The origin and liver repopulating capacity of murine oval cells

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 SEP 30; 100: 11881-11888

202

4807

4807 Kolb HJ, Schmid C, Chen XA, Woiciechowski A, Roskrow M, et al.

Adoptive immunotherapy in chimeras with donor lymphocytes

ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 110-120

4808

4808 Kramm CM

Alternative concepts of suicide gene therapy for graft-versus-host disease after adoptive immunotherapy

ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 132-138

4809

4809 Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, et al.

Infliximab for steroid-refractory acute GVHD: A case series

AMERICAN JOURNAL OF HEMATOLOGY. 2003 OCT; 74 (2): 119-124

4810

4810 Nachbaur D, Larcher C, Kircher B, Eibl G, Nussbaumer W, et al.

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation

ANNALS OF HEMATOLOGY. 2003 OCT; 82 (10): 621-627

Date / Author / Journal

LCS

GCS

LCR

4811

4811 Shapiro R, Jordan ML, Basu A, Scantlebury V, Potdar S, et al.

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning

ANNALS OF SURGERY. 2003 OCT; 238 (4): 520-525

4812

4812 Tewsa B, Wilhelm J, Summerer D, Strerath M, Marx A, et al.

Application of the C4 '-alkylated deoxyribose primer system (CAPS) in allele-specific real-time PCR for increased selectivity in discrimination of single nucleotide sequence variants

BIOLOGICAL CHEMISTRY. 2003 OCT-NOV; 384 (10-11): 1533-1541

4813

4813 Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, et al.

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 OCT; 9 (10): 616-632

4814

4814 Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, et al.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 OCT; 9 (10): 649-656

4815

4815 Takeuchi Y, Yoshizaki G, Takeuchi T

Generation of live fry from intraperitoneally transplanted primordial germ cells in rainbow trout

BIOLOGY OF REPRODUCTION. 2003 OCT; 69 (4): 1142-1149

4816

4816 Chou PM, Olszewski M, Huang W, Silva M, Kletzel M

Platelet chimerism by polymerase chain reaction (PCR) utilizing variable number of tandem repeats (VNTR) in allogeneic stem cell transplant in children: a new novel approach to full chimerism analysis

BONE MARROW TRANSPLANTATION. 2003 OCT; 32 (8): 825-828

4817

4817 Baron F, Baudoux E, Frere P, Tourqui S, Schaaf-Lafontaine N, et al.

Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC

BONE MARROW TRANSPLANTATION. 2003 OCT; 32 (8): 829-834

4818

4818 Nachbaur D, Kircher B, Eisendle K, Latzer K, Haun M, et al.

Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation

BRITISH JOURNAL OF HAEMATOLOGY. 2003 OCT; 123 (1): 119-126

4819

4819 D'Sa S, Peggs K, Pizzey A, Verfuerth S, Thuraisundaram D, et al.BRITISH JOURNAL OF HAEMATOLOGY. 2003 OCT; 123 (2): 309-322

4820

4820 Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, et al.

A novel monoclonal antibody design for radioimmunotherapy

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2003 OCT; 18 (5): 751-759

Date / Author / Journal

LCS

GCS

LCR

4821

4821 Reams D, McAdams HP, Howell DN, Steele MP, Davis RD, et al.

Posttransplant lymphoproliferative disorder - Incidence, presentation, and response to treatment in lung transplant recipients

CHEST. 2003 OCT; 124 (4): 1242-1249

4822

4822 Petruzzo P, Revillard JP, Kanitakis J, Lanzetta M, Hakim NS, et al.

First human double hand transplantation: efficacy of a conventional immunosuppressive protocol

CLINICAL TRANSPLANTATION. 2003 OCT; 17 (5): 455-460

4823

4823 Ruhin B, Creuzet S, Vincent C, Benouaiche L, Le Douarin NM, et al.

Patterning of the hyoid cartilage depends upon signals arising from the ventral foregut endoderm

DEVELOPMENTAL DYNAMICS. 2003 OCT; 228 (2): 239-246

4824

4824 Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, et al.

Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells

DIABETOLOGIA. 2003 OCT; 46 (10): 1366-1374

115

4825

4825 Xanthou G, Williams TJ, Pease JE

Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation

EUROPEAN JOURNAL OF IMMUNOLOGY. 2003 OCT; 33 (10): 2927-2936

4826

4826 Turgeon NA, Banuelos SJ, Shultz LD, Lyons BL, Iwakoshi N, et al.

Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta(2)-microglobulin-null mice

EXPERIMENTAL BIOLOGY AND MEDICINE. 2003 OCT; 228 (9): 1096-1104

4827

4827 Barge RMY, Osanto S, Marijt WAFE, Starrenburg CWJI, Fibbe WE, et al.EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 865-872

4828

4828 Faucher C, Mohty M, Vey N, Gaugler B, Bilger K, et al.

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen

EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 873-880

4829

4829 Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, et al.

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507

EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 911-923

4830

4830 Wu CJ, Hochberg EP, Rogers SA, Kutok JL, Biernacki M, et al.

Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation

EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 924-933

Date / Author / Journal

LCS

GCS

LCR

4831

4831 Fernandez-Aviles F, Urbano-Ispizua A, Aymerich M, Rovira M, Martinez C, et al.

Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases

EXPERIMENTAL HEMATOLOGY. 2003 OCT; 31 (10): 934-940

4832

4832 Yamaha E, Murakami M, Hada K, Otani S, Fujimoto T, et al.

Recovery of fertility in male hybrids of a cross between goldfish and common carp by transplantation of PGC (primordial germ cell)-containing graft

GENETICA. 2003 OCT; 119 (2): 121-131

4833

4833 Clouston A, Vanags DM, Gu WY, Powell EE, Jonsson JR

Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism.

HEPATOLOGY. 2003 OCT; 38 (4): 371A-371A

4834

4834 Ng IOL, Chan KL, Shek WH, Lee JMF, Fong DYT, et al.

High frequency of chimerism in transplanted livers

HEPATOLOGY. 2003 OCT; 38 (4): 989-998

4835

4835 Ansari MJI, Abdi R

Emerging immunomodulatory therapies targeting the co-stimulatory pathways for the prevention of transplant rejection

IDRUGS. 2003 OCT; 6 (10): 964-969

4836

4836 Jin YZ, Zhang QY, Hao B, Gao X, Guo YL, et al.

Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA41g gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats

IMMUNOLOGY. 2003 OCT; 110 (2): 275-286

4837

4837 Slavin S

Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2003 OCT; 78 (3): 195-207

4838

4838 Gordon N, Mullen CA, Tran H, Worth L, Almaguer DG, et al.

Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2003 OCT; 25 (10): 824-826

4839

4839 Matthes-Martin S, Lion T, Haas OA, Frommlet F, Daxberger H, et al.

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection

LEUKEMIA. 2003 OCT; 17 (10): 1934-1942

4840

4840 Tamaki H, Ikegame K, Kawakami M, Fujioka T, Tsuboi A, et al.

Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin

LEUKEMIA. 2003 OCT; 17 (10): 2052-2054

Date / Author / Journal

LCS

GCS

LCR

4841

4841 Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST

Facilitating cells as a venue to establish mixed chimerism and tolerance

PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 348-357

4842

4842 Venzke A, Ganschow R, Grabhorn E, Rogiers X, Burdelski M

Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy

PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 404-407

4843

4843 Maksimenko A, Malvy C, Lambert G, Bertrand JR, Fattal E, et al.

Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies

PHARMACEUTICAL RESEARCH. 2003 OCT; 20 (10): 1565-1567

4844

4844 Brocca S, Secundo F, Ossola M, Alberghina L, Carrea G, et al.

Sequence of the lid affects activity and specificity of Candida rugosa lipase isoenzymes

PROTEIN SCIENCE. 2003 OCT; 12 (10): 2312-2319

4845

4845 Pruss A, Heymann GA, Hell A, Kalus UJ, Krausch D, et al.

Acute intravascular hemolysis after transfusion of a chimeric RBC unit

TRANSFUSION. 2003 OCT; 43 (10): 1449-1451

4846

4846 Zhou W, Ohdan H, Tanaka Y, Hara H, Tokita D, et al.

NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant

TRANSPLANT IMMUNOLOGY. 2003 OCT-NOV; 12 (1): 9-18

4847

4847 Bittmann I, Bottino A, Baretton GB, Gerbes AL, Zachoval R, et al.

The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation-a clinico-pathological study

VIRCHOWS ARCHIV. 2003 OCT; 443 (4): 541-548

4848

4848 van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MCH, de Weger RA, et al.

A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2(-/-) gamma c(-/-) double-mutant mice

BLOOD. 2003 OCT 1; 102 (7): 2522-2531

4849

4849 Horwitz ME, Uzel G, Linton GF, Miller JA, Brown MR, et al.

Persistent Mycobactetium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency

BLOOD. 2003 OCT 1; 102 (7): 2692-2694

4850

4850 Creevy KE, Bauer TR, Tuschong LM, Embree LJ, Silverstone AM, et al.

Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 2003 OCT 15; 95 (3-4): 113-121

Date / Author / Journal

LCS

GCS

LCR

4851

4851 Xu QB, Zhang ZY, Davison F, Hu YH

Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice

CIRCULATION RESEARCH. 2003 OCT 17; 93 (8): E76-E86

4852

4852 Avivi I, Robinson S, Goldstone A

Clinical use of rituximab in haematological malignancies

BRITISH JOURNAL OF CANCER. 2003 OCT 20; 89 (8): 1389-1394

4853

4853 Schott E, Bonasio R, Ploegh HL

Elimination in vivo of developing T cells by natural killer cells

JOURNAL OF EXPERIMENTAL MEDICINE. 2003 OCT 20; 198 (8): 1213-1224

4854

4854 Takatu A, Nash RA, Zaucha YM, Little MT, Georges GE, et al.

Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 NOV; 9 (11): 674-682

4855

4855 Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, et al.

Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 NOV; 9 (11): 689-697

4856

4856 Lee JJ, Nam CE, Kook H, Maciejewski JP, Kim YK, et al.

Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation

BONE MARROW TRANSPLANTATION. 2003 NOV; 32 (9): 947-952

4857

4857 van Royen-Kerkhof A, Wulffraat NM, Kamphuis SSM, Brooimans RA, de Weger RA, et al.

Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodefficient patient

BONE MARROW TRANSPLANTATION. 2003 NOV; 32 (10): 1027-1030

4858

4858 Luft T, Moos M, Goldschmidt H, Ho AD, Gorner M

Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma

BRITISH JOURNAL OF HAEMATOLOGY. 2003 NOV; 123 (4): 646-653

4859

4859 Leckel K, Beecken WD, Jonas D, Oppermann E, Coman MC, et al.

The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003 NOV; 134 (2): 238-245

4860

4860 Santmyire-Rosenberger B, Dugan EM

Skin involvement in dermatomyositis

CURRENT OPINION IN RHEUMATOLOGY. 2003 NOV; 15 (6): 714-722

Date / Author / Journal

LCS

GCS

LCR

4861

4861 Alexandre P, Wassef M

The isthmic organizer links anteroposterior and dorsoventral patterning in the mid/hindbrain by generating roof plate structures

DEVELOPMENT. 2003 NOV; 130 (22): 5331-5338

4862

4862 Chen HR, Ji SQ, Wang HX, Yan HM, Zhu L, et al.

Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion

EXPERIMENTAL HEMATOLOGY. 2003 NOV; 31 (11): 1019-1025

4863

4863 Barker JE, Schuldt AJT, Lessard ML, Jude CD, Vogler CA, et al.

Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII

EXPERIMENTAL HEMATOLOGY. 2003 NOV; 31 (11): 1112-1118

4864

4864 Faden RR, Dawson L, Bateman-House AS, Agnew DM, Bok H, et al.

Public stem cell banks: Considerations of justice in stem cell research and therapy

HASTINGS CENTER REPORT. 2003 NOV-DEC; 33 (6): 13-27

4865

4865 Sato Y, Ichida T, Watanabe H, Yamamoto S, Abo T, et al.

Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation

HEPATO-GASTROENTEROLOGY. 2003 NOV-DEC; 50 (54): 2161-2165

4866

4866 Margalit A, Fishman S, Berko D, Engberg J, Gross G

Chimeric beta 2 microglobulin/CD3 zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells

INTERNATIONAL IMMUNOLOGY. 2003 NOV; 15 (11): 1379-1387

4867

4867 Neff T, Horn PA, Peterson LJ, Thomasson BM, Thompson J, et al.

Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model

JOURNAL OF CLINICAL INVESTIGATION. 2003 NOV; 112 (10): 1581-1588

4868

4868 Muramatsu K, Valenzuela RG, Bishop AT

Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer

JOURNAL OF ORTHOPAEDIC RESEARCH. 2003 NOV; 21 (6): 1056-1062

4869

4869 Muramatsu K, Kurokawa Y, Ihara K, Sakamoto S, Song YX, et al.

Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation

JOURNAL OF SURGICAL RESEARCH. 2003 NOV; 115 (1): 106-112

4870

4870 van Poelgeest EP, Baelde HJ, Lagaaij EL, Sijpkens YWJ, de Heer E, et al.

Endothelial cell chimerism after kidney transplantation occurs preferentially in women.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003 NOV; 14: 416A-416A

Date / Author / Journal

4871

Mantle cell lymphoma: Non-myeloablative versus dose-intensive therapy

LEUKEMIA & LYMPHOMA. 2003 NOV; 44: S69-S75

4872

4872 Turkiewicz D, Gorczynska E, Toporski J, Kalwak K, Rybka B, et al.

Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes

LEUKEMIA RESEARCH. 2003 NOV; 27 (11): 993-998

4873

4873 Olszewski WL, Interewicz B, Maksymowicz M, Durlik M

Biological aspects of limb transplantation: I. Migration of transplanted bone marrow cells into recipient

PLASTIC AND RECONSTRUCTIVE SURGERY. 2003 NOV; 112 (6): 1628-1635

4874

4874 Ebrahimi-Rad M, Nikbin B, Mehrsai A, Pourmand G

Outcome of 18 cases of simultaneous kidney and donor-specific bone marrow transplantation

TRANSPLANTATION PROCEEDINGS. 2003 NOV; 35 (7): 2761-2762

4875

4875 van Tellingen O, Buckle T, Jonker JW, van der Valk MA, Beijnen JH

P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo

BRITISH JOURNAL OF CANCER. 2003 NOV 3; 89 (9): 1776-1782

4876

4876 Strutz-Seebohm N, Werner M, Madsen DM, Seebohm G, Zheng Y, et al.

Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 7; 278 (45): 44691-44701

4877

4877 Heemskerk MHM, Hoogeboom M, de Paus RA, Kester MGD, van der Hoorn MAWG, et al.BLOOD. 2003 NOV 15; 102 (10): 3530-3540

4878

4878 Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, et al.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

BLOOD. 2003 NOV 15; 102 (10): 3829-3836

102

4879

4879 Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, et al.

Male DNA in female donor apheresis and CD34-enriched products

BLOOD. 2003 NOV 15; 102 (10): 3845-3847

4880

4880 Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL

Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block

LANCET. 2003 NOV 15; 362 (9396): 1617-1623

Date / Author / Journal

LCS

GCS

LCR

4881

4881 Sun WJ, Wang QX, Zhang LH, Liu YS, Zhang M, et al.

Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin

TRANSPLANTATION. 2003 NOV 15; 76 (9): 1351-1359

4882

4882 Juliusson G, Malm C, Karlsson K, Backstrom G

Donor-derived epithelial cells in buccal mucosa smears following allogeneic hematopoietic stem cell transplantation in 54 patients: Usually mixed chimerism, but level not related to procedure, time after transplantation, or graft-versus-host disease.

BLOOD. 2003 NOV 16; 102 (11): 155B-155B

4883

4883 Panse JP, Heimfeld S, Guthrie KA, Maris M, Maloney DG, et al.

Allogeneic peripheral blood graft composition affects early T-cell chimerism and later clinical outcomes after nonmyeloablative conditioning.

BLOOD. 2003 NOV 16; 102 (11): 240A-240A

4884

4884 Abdulmalik O, Hayashi S, Merchant A, Chen QK, Yang JS, et al.

Complete correction of sickle cell disease pathophysiology in high-level allogeneic chimeras created by a strategy of in utero hematopoietic cell transplantation with postnatal enhancement of chimerism.

BLOOD. 2003 NOV 16; 102 (11): 263A-263A

4885

4885 Berger MG, Gallot D, Tchirkov A, Berger J, Pigeon P, et al.

Mesenchymal cells improved human/rat microchimerism in Wistar rat after in utero transplantation (IUT).

BLOOD. 2003 NOV 16; 102 (11): 394B-394B

4886

4886 Saito A, Chiba S, Ogawa S, Kanda Y, Hirai H

Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia.

BLOOD. 2003 NOV 16; 102 (11): 394B-394B

4887

4887 Lee MJ, Seo JJ, Choi ES, Ghim TT

Is there a prognostic significance of mixed chimerism in children with acute leukemia after allogeneic bone marrow transplantation?

BLOOD. 2003 NOV 16; 102 (11): 398B-399B

4888

4888 Moustafa ME, Srivastava AS, Nedelcu E, Shenouda SS, Minev B, et al.

Chimerism and tolerance after in utero transplantation of ES cells.

BLOOD. 2003 NOV 16; 102 (11): 399B-399B

4889

4889 Lucesole M, Poloni A, Capelli D, Montanari M, Cecchi S, et al.

Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine.

BLOOD. 2003 NOV 16; 102 (11): 400B-400B

4890

4890 Milani R, Longoni P, Rizzo E, Carrabba M, Dodero A, et al.

Low-dose alemtuzumab in nonmyeloablative conditioning for allogeneic transplantation: Influence on recovery and chimerism of dendritic cells.

BLOOD. 2003 NOV 16; 102 (11): 401B-401B

Date / Author / Journal

LCS

GCS

LCR

4891

4891 Hirano T, Miyajima H, Tateno M, Okumura K, Oshimi K

Chimerism and graft-versus-tumor effect (GVT) on murine mini-transplantation model.

BLOOD. 2003 NOV 16; 102 (11): 403B-403B

4892

4892 Naparstek E, Vainas O, Eshel R

Real-time PCR SNP assay for monitoring chimerism after allogeneic stem cell transplantation.

BLOOD. 2003 NOV 16; 102 (11): 433B-433B

4893

4893 Matthes-Martin S, Lion T, Haas OA, Frommlet F, Peters C, et al.

Lineage-specific chimerism after stem cell transplantation in children following reduced intensity conditioning: Potential predictive value of NK cell chimerism for late graft rejection.

BLOOD. 2003 NOV 16; 102 (11): 454A-455A

4894

4894 Bauer TR, Creevy KE, Gu YC, Tuschong LM, Embree LJ, et al.

Stable mixed chimerism following a non-myeloabative transplant regimen corrects the disease phenotype in dogs with the primary immunodeficiency disease canine leukocyte adhesion deficiency.

BLOOD. 2003 NOV 16; 102 (11): 456A-456A

4895

4895 Shields LE, Gaur LK, Andrews RG

Chimerism after in utero hematopoietic stem cell transplantation in non-human primates is unchanged by fetal immune suppression or postnatal donor stem cell infusion.

BLOOD. 2003 NOV 16; 102 (11): 456A-456A

4896

4896 Fukuda T, Storb R, Gooley T, Santos EB, Sandmaier BM

DLA-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning: Achievement of full donor chimerism by donor lymphocyte infusion.

BLOOD. 2003 NOV 16; 102 (11): 458A-458A

4897

4897 De Angelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, et al.

Extended follow-up of patients treated with imatinib mesylate (Gleevec (R)) for CML relapse following allogeneic transplantation: Durable cytogenetic remission and conversion to complete donor chimerism without GVHD.

BLOOD. 2003 NOV 16; 102 (11): 462B-462B

4898

4898 Huff CA, Jones RJ, Flinn I, Vogelsang GB, Luznik L, et al.

Full donor chimerism is required for stable engraftment and durable disease control after nonmyeloablative (NM) allogeneic blood or marrow transplants (BMT).

BLOOD. 2003 NOV 16; 102 (11): 467A-467A

4899

4899 Burt RK, Oyama Y, Traynor A, Verda L, Barr W

Complete remission of rheumatoid arthritis following allogeneic hematopoietic stem cell transplantation induced mixed chimerism.

BLOOD. 2003 NOV 16; 102 (11): 468B-468B

4900

4900 Michallet ASAS, Nicolini FF, Tremisi JPJP, Dubois VV, Hayette SS, et al.

Analyzis of the toxicity and efficacy of donor lymphocyte infusions (DLI) after reduced intensity conditioning regimen allogeneic transplantations (RICT), given for either mixed chimerism and/or persistent disease.

BLOOD. 2003 NOV 16; 102 (11): 470B-470B

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records